Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
UnitedHealth's rough stretch continues, with buyouts, a reported DOJ probe and a 23% drop in three months
Once high-flying Bluebird Bio sells itself to private equity after tough times for the gene therapy maker
BP Life: Championing Transparency and Health with High-Purity Fenbendazole
From pills to new uses, here's what Eli Lilly’s top scientist sees as the future of weight loss drugs
Eli Lilly aims to invest in 'big problems hiding in plain sight' using obesity windfall
UnitedHealthcare is offering buyouts to employees in benefits unit, could pursue layoffs, sources say
